PQ Bypass Overview

  • Founded
  • 2009
Founded
  • Status
  • Acquired/​Merged
  • Employees
  • 33
Employees
  • Latest Deal Type
  • M&A

PQ Bypass General Information

Description

Developer of medical devices intended to transform the treatment of long-segment femoropopliteal disease with minimally-invasive endovascular solutions. The company's devices are designed to present a novel, percutaneous approach to the bypass surgery and offer potential to be powerful options for treating long-segment femoropopliteal disease, enabling medical practitioners to improve the quality of life for patients with peripheral artery disease.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Primary Industry
Surgical Devices
Other Industries
Therapeutic Devices
Parent Company
Primary Office
  • 1971 Milmont Drive
  • Milpitas, CA 95035
  • United States
+1 (408) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

PQ Bypass Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Merger/Acquisition 13-Apr-2021 00000 Completed Generating Revenue
5. Later Stage VC (Series C) 14-Jan-2019 0000 00000 Completed Generating Revenue
4. Later Stage VC 13-Feb-2018 00.000 000.00 Completed Generating Revenue
3. Later Stage VC (Series B) 22-Apr-2016 0000 000.00 000.00 Completed Generating Revenue
2. Later Stage VC (Series A) 01-Apr-2015 $5.04M $20M 000.00 Completed Generating Revenue
1. Early Stage VC (Series A) 25-Feb-2013 $15M $15M 000.00 Completed Startup
To view PQ Bypass’s complete valuation and funding history, request access »

PQ Bypass Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B 00,000,000 00.000000 00.00 00.00 00.00 00.00 00.000
Series A 00,000,000 00.000000 00.00 00.00 00.00 00.00 00.000
To view PQ Bypass’s complete cap table history, request access »

PQ Bypass Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of medical devices intended to transform the treatment of long-segment femoropopliteal disease with minimally-
Surgical Devices
Milpitas, CA
33 As of 2021
00000
000000&0 00000

000000 0

iquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum
00000000 0000000
Wayne, PA
00 As of 0000
000.00
00.00 0000-00-00
00000000000 000.00

00000000

strud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in
00000000 0000000
Santa Clara, CA
000 As of 0000
00000
000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

PQ Bypass Competitors (19)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Vesper Medical Venture Capital-Backed Wayne, PA 00 000.00 00000000000 000.00
000000000 0000000 Formerly VC-backed Santa Clara, CA 000 00000 000000000 00000
0000000000 (000000 Venture Capital-Backed Caesarea, Israel 00 00000 000000 00 00000
0000000000000 Corporation New York, NY 000 000000 - 000
0000000 0000000 Formerly VC-backed Boca Raton, FL 0 00.000 000000&0 00.000
You’re viewing 5 of 19 competitors. Get the full list »

PQ Bypass Executive Team (12)

Name Title Board Seat Contact Info
Steve Dick Consulting Chief Financial Officer
James Joye Co-Founder & Chief Medical Officer
Richard Heuser Co-Founder
Ziad Rouag JD Vice President of Regulatory & Clinical Affairs
Kumar Jambunathan Vice President, Product Development
You’re viewing 5 of 12 executive team members. Get the full list »

PQ Bypass Board Members (8)

Name Representing Role Since
Richard Ferrari Self Chairman, Chief Executive Officer and President 000 0000
Stanton Rowe Self Board Member 000 0000
You’re viewing 2 of 8 board members. Get the full list »

PQ Bypass Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

PQ Bypass Former Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Ascent Biomedical Ventures Venture Capital Minority 000 0000 000000 0
Deerfield Management Venture Capital Minority 000 0000 000000 0
Fogarty Institute for Innovation Accelerator/Incubator Minority 000 0000 000000 0
Kinled Holding Venture Capital Minority 000 0000 000000 0
Michael Jaff Angel (individual) Minority 000 0000 000000 0
You’re viewing 5 of 6 investors. Get the full list »